NichibanNICHIBAN CO., LTD4218東証プライム化学FY ending Mar 2026, consolidated, J-GAAP
Revenue by business segment, and the profit each one keeps.
Geographic revenue reported in annual filings
No geographic revenue breakdown was disclosed.
※ Segment figures include inter-segment sales and do not sum to the company total
X-axis: segment revenue CAGR. Y-axis: latest operating margin. Bubble size: revenue.
Bubble size represents latest revenue. Segments without a CAGR are placed at the left edge; their horizontal position is not a growth value. Color indicates positive or negative margin.
| Segment | Revenue CAGR | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|---|
| Medical business | +7.1%5y | 19,08022.0% | 20,99222.8% | 22,74426.8% | 24,58426.9% | 24,93625.4% |
| Tape business | +1.4%5y | 24,0549.1% | 24,5683.9% | 24,1151.2% | 24,8732.8% | 25,5343.2% |
Top: revenue. Bottom: operating margin.
EDINET (FSA Japan)
有価証券報告書－第122期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第121期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第120期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第119期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第118期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第117期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 49 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.